scispace - formally typeset
R

Rajiv Agarwal

Researcher at Katholieke Universiteit Leuven

Publications -  4
Citations -  197

Rajiv Agarwal is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Hemodialysis & End stage renal disease. The author has an hindex of 4, co-authored 4 publications receiving 142 citations. Previous affiliations of Rajiv Agarwal include Indiana University.

Papers
More filters
Journal ArticleDOI

Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*

TL;DR: An overview of the diagnosis, epidemiology, pathogenesis and treatment of hypertension in patients on dialysis, aiming to offer the renal physician practical recommendations based on current knowledge and expert opinion and to highlight areas for future research.
Journal ArticleDOI

Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis

TL;DR: In 6 hyperkalemic HD patients, patiromer decreased serum K and P levels and increased fecal K, and while on patiromers, fecal P numerically increased by 112 ± 72 mg/day (17%; p = 0.04).
Journal ArticleDOI

Hypertension in dialysis patients : a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)

TL;DR: An overview of the diagnosis, epidemiology, pathogenesis and treatment of hypertension in patients on dialysis, aiming to offer the renal physician practical recommendations based on current knowledge and expert opinion and to highlight areas for future research as mentioned in this paper.

Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis

TL;DR: In this paper, persistent hyperkalemia (serum potassium (K ≥ 5.5 mEq/l) is associated with increased mortality in hemodialysis patients.